Literature DB >> 24043788

Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses.

Boris Essere1, Matthieu Yver, Cyrille Gavazzi, Olivier Terrier, Catherine Isel, Emilie Fournier, Fabienne Giroux, Julien Textoris, Thomas Julien, Clio Socratous, Manuel Rosa-Calatrava, Bruno Lina, Roland Marquet, Vincent Moules.   

Abstract

The fragmented nature of the influenza A genome allows the exchange of gene segments when two or more influenza viruses infect the same cell, but little is known about the rules underlying this process. Here, we studied genetic reassortment between the A/Moscow/10/99 (H3N2, MO) virus originally isolated from human and the avian A/Finch/England/2051/91 (H5N2, EN) virus and found that this process is strongly biased. Importantly, the avian HA segment never entered the MO genetic background alone but always was accompanied by the avian PA and M fragments. Introduction of the 5' and 3' packaging sequences of HA(MO) into an otherwise HA(EN) backbone allowed efficient incorporation of the chimerical viral RNA (vRNA) into the MO genetic background. Furthermore, forcing the incorporation of the avian M segment or introducing five silent mutations into the human M segment was sufficient to drive coincorporation of the avian HA segment into the MO genetic background. These silent mutations also strongly affected the genotype of reassortant viruses. Taken together, our results indicate that packaging signals are crucial for genetic reassortment and that suboptimal compatibility between the vRNA packaging signals, which are detected only when vRNAs compete for packaging, limit this process.

Entities:  

Keywords:  RNA packaging; hemagglutinin

Mesh:

Substances:

Year:  2013        PMID: 24043788      PMCID: PMC3791739          DOI: 10.1073/pnas.1308649110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging.

Authors:  Qinshan Gao; Yi-Ying Chou; Sultan Doğanay; Reza Vafabakhsh; Taekjip Ha; Peter Palese
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Atypical characteristics of nucleoprotein of pandemic influenza virus H1N1 and their roles in reassortment restriction.

Authors:  Asawin Wanitchang; Prasatha Patarasirin; Juggragarn Jengarn; Anan Jongkaewwattana
Journal:  Arch Virol       Date:  2011-02-22       Impact factor: 2.574

3.  Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence.

Authors:  Chengjun Li; Masato Hatta; Chairul A Nidom; Yukiko Muramoto; Shinji Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

4.  A distinct lineage of influenza A virus from bats.

Authors:  Suxiang Tong; Yan Li; Pierre Rivailler; Christina Conrardy; Danilo A Alvarez Castillo; Li-Mei Chen; Sergio Recuenco; James A Ellison; Charles T Davis; Ian A York; Amy S Turmelle; David Moran; Shannon Rogers; Mang Shi; Ying Tao; Michael R Weil; Kevin Tang; Lori A Rowe; Scott Sammons; Xiyan Xu; Michael Frace; Kim A Lindblade; Nancy J Cox; Larry J Anderson; Charles E Rupprecht; Ruben O Donis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

5.  Competitive incorporation of homologous gene segments of influenza A virus into virions.

Authors:  Arisa Inagaki; Hideo Goto; Satoshi Kakugawa; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

6.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding.

Authors:  Takeo Gorai; Hideo Goto; Takeshi Noda; Tokiko Watanabe; Hiroko Kozuka-Hata; Masaaki Oyama; Ryo Takano; Gabriele Neumann; Shinji Watanabe; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

8.  Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin.

Authors:  Troy D Cline; Erik A Karlsson; Pamela Freiden; Bradley J Seufzer; Jerold E Rehg; Richard J Webby; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

9.  Reassortment between seasonal H1N1 and pandemic (H1N1) 2009 influenza viruses is restricted by limited compatibility among polymerase subunits.

Authors:  Cássio Pontes Octaviani; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

10.  A supramolecular assembly formed by influenza A virus genomic RNA segments.

Authors:  Emilie Fournier; Vincent Moules; Boris Essere; Jean-Christophe Paillart; Jean-Daniel Sirbat; Catherine Isel; Annie Cavalier; Jean-Paul Rolland; Daniel Thomas; Bruno Lina; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

View more
  54 in total

1.  Computational and molecular analysis of conserved influenza A virus RNA secondary structures involved in infectious virion production.

Authors:  Yuki Kobayashi; Bernadeta Dadonaite; Neeltje van Doremalen; Yoshiyuki Suzuki; Wendy S Barclay; Oliver G Pybus
Journal:  RNA Biol       Date:  2016-07-11       Impact factor: 4.652

2.  Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.

Authors:  Kara L Phipps; Nicolle Marshall; Hui Tao; Shamika Danzy; Nina Onuoha; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus.

Authors:  Isabel Wendel; Dennis Rubbenstroth; Jennifer Doedt; Georg Kochs; Jochen Wilhelm; Peter Staeheli; Hans-Dieter Klenk; Mikhail Matrosovich
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

4.  RNA structural constraints in the evolution of the influenza A virus genome NP segment.

Authors:  Alexander P Gultyaev; Anton Tsyganov-Bodounov; Monique I J Spronken; Sander van der Kooij; Ron A M Fouchier; René C L Olsthoorn
Journal:  RNA Biol       Date:  2014-07-23       Impact factor: 4.652

5.  Heterologous Packaging Signals on Segment 4, but Not Segment 6 or Segment 8, Limit Influenza A Virus Reassortment.

Authors:  Maria C White; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

6.  The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.

Authors:  Manuel Rosa-Calatrava; Olivier Terrier; Julia Dubois; Aurélien Traversier; Thomas Julien; Blandine Padey; Bruno Lina; Jean-Christophe Bourdon; Virginie Marcel; Guy Boivin
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 7.  Population Diversity and Collective Interactions during Influenza Virus Infection.

Authors:  Christopher B Brooke
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 8.  Development and applications of single-cycle infectious influenza A virus (sciIAV).

Authors:  Aitor Nogales; Steven F Baker; William Domm; Luis Martínez-Sobrido
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

9.  Influenza virus PB1 and neuraminidase gene segments can cosegregate during vaccine reassortment driven by interactions in the PB1 coding region.

Authors:  Joanna C A Cobbin; Chi Ong; Erin Verity; Brad P Gilbertson; Steven P Rockman; Lorena E Brown
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

10.  Influenza A and B virus intertypic reassortment through compatible viral packaging signals.

Authors:  Steven F Baker; Aitor Nogales; Courtney Finch; Kevin M Tuffy; William Domm; Daniel R Perez; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.